GSK Says No Link Between Zofran, Defects Undermines MDL
By Chris Villani · March 24, 2021, 3:59 PM EDT
Lawyers for GlaxoSmithKline argued Wednesday that more than 300 cases in a multidistrict product liability suit over its anti-nausea medication should be nixed since the plaintiffs' own expert determined there is...
To view the full article, register now.